Skip to main content

Protection Against jumping Genes

Tight DNA Packaging Protect Against 'Jumping Genes' Potentially Cellular Destruct.

#INTRODUCTION

Transposable elements are sometimes called "jumping genes." They consist of segments of DNA that can move from one position on a chromosome to another. In 1951, Nobel prize-winning Dr. Barbara McClintock proposed that genes are not fixed on chromosomes, but that they can move around on the chromosome. At first her findings were discarded because they contradicted the genetic concept of the day. Today, her discovery of what she calls transposable elements has an established place in science.

#Discover 

UNC School of Medicine researchers discovered that the major developmental function of heterochromatin – a form of tight DNA packaging found in chromosomes – is likely to suppress activity of virus-like DNA elements known as transposons or "jumping genes," which can otherwise copy and paste themselves throughout the genome, potentially destroying important genes, and causing cancers and other diseases.

The repression of transposon mobilization is necessary to maintain genome stability, and we now think this repression may be the major developmental function of heterochromatin, rather than a role in controlling gene expression and cell proliferation.

Chromatin, essentially, is the spooled structure DNA takes when packaged inside cells. The two broad forms of chromatin are euchromatin, a loose structure normally considered permissive for gene activity and the encoding of proteins; and heterochromatin, a tighter, denser packaging of DNA thought principally to suppress gene activity. The tightest and most stable form of heterochromatin, known as constitutive heterochromatin, is found mostly at the constricted region of chromosomes, which is the region important for chromosome movement during cell division.

Although various functions have been attributed to heterochromatin, these functions have not been easy to confirm with definitive experiments. The standard experimental approach has been to observe what happens when heterochromatin formation is blocked, but the process that triggers the formation of heterochromatin is hard to block precisely.

The current model holds that heterochromatin forms when a protein called histone H3 is chemically modified – or methylated – at a key site.

#Principle 

replacing normal histone H3 genes with mutant versions that can't be methylated at the key site would block heterochromatin formation and be an important test of the current model. In practice, however, it is virtually impossible to do this experiment in higher animals such as lab mice.

#Mechanism

"Mice, as well as humans, have three different clusters of histone genes on different chromosomes, and so creating genetic manipulations at those different spots is very difficult, especially because there are other essential genes within those histone gene clusters," said Taylor J. R. Penke, a graduate student in the Duronio Lab who was first author of the study.

Fortunately, another standard lab animal, the Drosophila fruit fly, has a more targetable set of histone genes.

"The histone H3 genes we wanted to change are clustered in one location in the genome of a fruit fly, without other essential genes in the cluster, so they can all be removed at once and replaced with mutant histone H3 genes," said Penke.

For the new study, Penke, Duronio, and their colleagues used an advanced Drosophila genetics platform they developed last year to replace these histone H3 genes with mutant versions that don't permit the methylation that triggers heterochromatin formation.

The first surprise was that the Drosophila mutants did not all die before adulthood; about two percent survived. Among the surviving flies, there was a sharp drop in signs of heterochromatin in their chromosomes, especially where the histone H3 methylated proteins are normally concentrated. Moreover, despite the long-held assumption that heterochromatin regulates gene activity, the UNC scientists found that gene expression in the mutants was mostly unchanged, even in the regions where the tight heterochromatin packaging of DNA had been relaxed.

There was one big change in the mutants, however. The regions of their chromosomes that would normally be strongly heterochromatic showed a jump in the activity of transposons. These DNA elements – whose evolutionary origins are murky but make up large fractions of plant and animal genomes – have a virus-like tendency to make copies of themselves by snipping themselves out of their original locations and re-inserting themselves elsewhere in the genome. Along with an increase in transposon activity, the team found signs that a key anti-transposon defense mechanism had been activated. That is, levels of piRNA transcripts – the precursors to small RNA molecules that bind to transposons to block their activity – were sharply increased.

Although transposons are thought to benefit their hosts in certain circumstances, they clearly can cause harm. Duronio, Penke, and colleagues suspect that the 98 percent mortality among their Drosophila mutants and the high death rate thereafter among surviving flies were due largely to the effects of transposons inserting themselves in the genome and disrupting key genes.

"It seems that the major role for the methylation of histone H3 that triggers this type of heterochromatin is to keep transposons from jumping around and screwing up the genome," Duronio said.

Human histone H3 genes are quite similar to those in Drosophila, suggesting that their function has largely been conserved despite the evolutionary gulf between flies and humans. This suggests that Drosophila is a good model for the study of human histone function.

Understanding better how the genome normally defends itself from transposons should help scientists get a better handle on transposon-related diseases. Transposons can directly trigger cancerous changes in a cell, for example, by disrupting a tumor-suppressor gene or by causing a DNA break that destabilizes a large section of the chromosome. Cases of many other diseases, including hemophilia, have been linked to transposons' disruption of important genes.

"During embryonic and fetal development, there is normally a high-fidelity replication of the genome, and that is a significant mechanism

Soure of the story: phy.org

Comments

Popular posts from this blog

The New Blood Group 'INRA'

Usually there are 4 or 5 blood groups to be known namely A,B,O,AB and rarely Bombay or HH blood group. The Bombay blood group are named after its discovery in the city Bombay (now called Mumbai city)discover by the Dr. Y.M. Bhende in 1952  and this is the first time India become a parent of the new and rarest type of blood group. It is obvious,Bomby blood group is the first blood group found in India but not the least "because discovery never stops" This saying fix here perfectly,A person with new & rare blood group is found in Lok Samparn Raktdan laboratory, Surat, Gujarat. The person’s blood group doesn’t match with any other A, B, O, AB and also Bombay Blood Group or also called as HH Blood Group. The new blood group is named as INRA; the first 2 letters represent India (IN) & the next two name of the person (RA). INRA blood group is identified for the first time when the person visited for donating blood in Blood Camp. The blood sample was prev

Autophagy: A Nobel Prize Topic

        Introduction The word autophagy is derived from Greek words “auto” meaning self and “phagy” meaning eating. Autophagy is a normal physiological process in the body that deals with destruction of cells in the body. It maintains homeostasis or normal functioning by protein degradation and turnover of the destroyed cell organelles for new cell formation. During cellular stress the process of Autophagy is upscaled and increased. Cellular stress is caused when there is deprivation of nutrients and/or growth factors. Thus Autophagy may provide an alternate source of intracellular building blocks and substrates that may generate energy to enable continuous cell survival. History Autophagy has been known for over 50 years but its fundamental importance in physiology and medicine was only recognized after Yoshinori Ohsumi's paradigm-shifting research in the 1990's. For his discoveries, he is awarded this year's Nobel Prize in physiology or medicine.

Artificial Cancer-Killing Virus

It is the genome of an oncolytic virus, it is 34,000 base pairs long, and it is 100% artificial. It’s important because it not only has immediate application in studies of canine cancer, it also promises to inform the development of human therapies. In these human therapies, artificial viruses could be customized to such an extent, that they could qualify as personalized anticancer therapeutics.  It is not the first time that oncolytic viruses has engineered but earlier virus like Herpes simplex and Oncorine(H101) are also being used.  The virus in question in sCAV2, a conditionally replicative adenovirus (CRAd) that can target and kill tumor cells while sparing healthy cells. It was synthesized by scientists affiliated with Gen9, who worked in concert with scientists representing Autodesk and Auburn University. At Auburn, scientists led by Bruce Smith, V.M.D., Ph.D., intend to use the synthetic virus to evaluate therapeutic treatments in dogs with osteosarcoma, a